Top Markets
Coin of the day
RBC Bioscience Corporation RBC Bioscience Corporation

RBC Bioscience Corporation

6848
Rang in Aktien #32481
RBC Bioscience Corporation is a firm dedicated to the research, development,... RBC Bioscience Corporation is a firm dedicated to the research, development, production, and sale of specialized reagents and advanced equipment. These products cater to the life sciences and molecular diagnostic sectors. Its market reach is extensive, covering Europe, the United States, Asia, Taiwan, Africa, and Australia. The company's diverse product line includes reagents tailored for molecular biomedical diagnostics and scientific research, alongside automated instruments for gene and nucleic acid extraction. It also provides a range of nucleic acid extraction kits and associated reagent tissues. Sales are primarily conducted through a global network of distributors. Established in 1995, RBC Bioscience Corporation maintains its headquarters in New Taipei City, Taiwan.
Aktienkurs
$0.70116857
Marktkapitalisierung
$10.01M
Veränderung (1 Tag)
0.23%
Veränderung (1 Jahr)
18.64%
Land
TW
Handel RBC Bioscience Corporation (6848)

Kategorie

Dividendenrendite-Verlauf für RBC Bioscience Corporation (6848)
Dividendenrendite (TTM) von RBC Bioscience Corporation (Aktienkürzel: 6848) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für RBC Bioscience Corporation (6848) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber